← Overview

Strategic Lens

Pharma and health: India and China

First country

Second country

In 2025, India sold USD 80.4 million of pharmaceutical products to China and bought USD 197 million from it.

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Last updated on 26 September 2026

The numbers

India's exports to China: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by India

2019: 44.3Low 44.3 / High 842025: 80.4

201944.3
202051.2
202155.4
202252.2
202374
202484
202580.4

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

India's imports from China: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by India

2019: 186Low 172.8 / High 215.82025: 196.8

2019186
2020184.9
2021215.8
2022179.6
2023172.8
2024196.2
2025196.8

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

More on this relationship

Benefits

  • IndiaAccess to Chinese inputs helps keep Indian medicine production costs low.

Constraints

  • IndiaA 2018 parliamentary committee flagged reliance on Chinese raw materials in pharmaceuticals.

Sources: Wikipedia: China–India relations (revision of 23 September 2026)

← India and China